Literature DB >> 12728719

Assessing bone formation using mouse calvarial organ cultures.

I Ross Garrett1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12728719     DOI： 10.1385/1-59259-366-6:183

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  10 in total

1.  Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo.

Authors:  J Frantzias; J G Logan; P Mollat; A Sparatore; P Del Soldato; S H Ralston; A I Idris
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Increasing the pore sizes of bone-mimetic electrospun scaffolds comprised of polycaprolactone, collagen I and hydroxyapatite to enhance cell infiltration.

Authors:  Matthew C Phipps; William C Clem; Jessica M Grunda; Gregory A Clines; Susan L Bellis
Journal:  Biomaterials       Date:  2011-10-19       Impact factor: 12.479

3.  Spatial mapping of mineralization with manganese-enhanced magnetic resonance imaging.

Authors:  Ingrid E Chesnick; Jose A Centeno; Todor I Todorov; Alan E Koenig; Kimberlee Potter
Journal:  Bone       Date:  2011-02-23       Impact factor: 4.398

4.  Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation.

Authors:  Gregory A Clines; Khalid S Mohammad; Yongde Bao; Owen W Stephens; Larry J Suva; John D Shaughnessy; Jay W Fox; John M Chirgwin; Theresa A Guise
Journal:  Mol Endocrinol       Date:  2006-10-26

5.  Stimulation of new bone formation by the proteasome inhibitor, bortezomib: implications for myeloma bone disease.

Authors:  Babatunde O Oyajobi; I Ross Garrett; Anjana Gupta; Alda Flores; Javier Esparza; Steve Muñoz; Ming Zhao; Gregory R Mundy
Journal:  Br J Haematol       Date:  2007-11       Impact factor: 6.998

6.  Pharmacological targeting of KDM6A and KDM6B, as a novel therapeutic strategy for treating craniosynostosis in Saethre-Chotzen syndrome.

Authors:  Clara Pribadi; Esther Camp; Dimitrios Cakouros; Peter Anderson; Carlotta Glackin; Stan Gronthos
Journal:  Stem Cell Res Ther       Date:  2020-12-09       Impact factor: 6.832

7.  FGFR2 Mutation p.Cys342Arg Enhances Mitochondrial Metabolism-Mediated Osteogenesis via FGF/FGFR-AMPK-Erk1/2 Axis in Crouzon Syndrome.

Authors:  Yidi Wang; Yue Liu; Haotian Chen; Xiaojing Liu; Yi Zhang; Yixiang Wang; Yan Gu
Journal:  Cells       Date:  2022-10-05       Impact factor: 7.666

8.  P38 and ERK1/2 MAPKs act in opposition to regulate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells.

Authors:  Yingze Zhao; Tao Song; Wenjuan Wang; Jin Wang; Juanwen He; Ningning Wu; Min Tang; Baicheng He; Jinyong Luo
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

9.  A targeted approach for evaluating preclinical activity of botanical extracts for support of bone health.

Authors:  Yumei Lin; Mary A Murray; I Ross Garrett; Gloria E Gutierrez; Jeffry S Nyman; Gregory Mundy; David Fast; Kevin W Gellenbeck; Amitabh Chandra; Shyam Ramakrishnan
Journal:  J Nutr Sci       Date:  2014-05-13

Review 10.  Use of in vitro bone models to screen for altered bone metabolism, osteopathies, and fracture healing: challenges of complex models.

Authors:  Sabrina Ehnert; Helen Rinderknecht; Romina H Aspera-Werz; Victor Häussling; Andreas K Nussler
Journal:  Arch Toxicol       Date:  2020-09-10       Impact factor: 5.153
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.